Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Oligodeoxyribonucleotides derived from salmon sperm DNA: an alternative to defibrotide.

Hui CY, Guo Y, Zhang X, Shao JH, Yang XQ, Zhang W.

Biologicals. 2013 May;41(3):190-6. doi: 10.1016/j.biologicals.2012.12.003. Epub 2013 Jan 30.

PMID:
23375586
[PubMed - indexed for MEDLINE]
2.

Investigation of the fibrinolytic activity of defibrotide fractions.

Hizal N, Bilsel S, Emerk K.

Gen Pharmacol. 1994 Dec;25(8):1617-20.

PMID:
7721037
[PubMed - indexed for MEDLINE]
3.

Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance.

Violi F, Ferro D, Saliola M, Quintarelli C, Basili S, Balsano F.

Eur J Clin Pharmacol. 1992;42(4):379-83.

PMID:
1516602
[PubMed - indexed for MEDLINE]
4.

Fibrinolytic effects of defibrotide in atherosclerotic patients.

Patrassi GM, Sartori MT, Viero ML, Scapinello MP, Boeri G, Girolami A.

Semin Thromb Hemost. 1991;17 Suppl 1:101-5.

PMID:
2068562
[PubMed - indexed for MEDLINE]
5.

Acute t-PA release by defibrotide.

Klöcking HP.

Thromb Res. 1992 Jun 15;66(6):779-85. No abstract available.

PMID:
1519236
[PubMed - indexed for MEDLINE]
6.

The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.

Echart CL, Graziadio B, Somaini S, Ferro LI, Richardson PG, Fareed J, Iacobelli M.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):627-34. doi: 10.1097/MBC.0b013e32832da1e3.

PMID:
19809307
[PubMed - indexed for MEDLINE]
7.

Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells.

Falanga A, Vignoli A, Marchetti M, Barbui T.

Leukemia. 2003 Aug;17(8):1636-42.

PMID:
12886253
[PubMed - indexed for MEDLINE]
8.

Morphological changes in carotid arteries of rabbits induced by defibrotide infusion.

Bilsel S, San T, Erşahin C, Moini H, Okar I, Emerk K.

Thromb Res. 1994 Dec 1;76(5):433-40.

PMID:
7900091
[PubMed - indexed for MEDLINE]
9.

Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patients.

Violi F, Ferro D, Alessandri C, Quintarelli C, Saliola M, Balsano F.

Semin Thromb Hemost. 1989 Apr;15(2):226-9.

PMID:
2501872
[PubMed - indexed for MEDLINE]
10.

Defibrotide is equipotent to urokinase in stimulating arterial and venous thrombolysis.

Grodzińska L, König E, Schrör K.

Pharmacol Res Commun. 1987 Sep;19(9):609-15.

PMID:
3432326
[PubMed - indexed for MEDLINE]
11.

Pharmacologic profiling of defibrotide in experimental models.

Fareed J, Walenga JM, Hoppensteadt DA, Kumar A, Ulutin ON, Cornelli U.

Semin Thromb Hemost. 1988;14 Suppl:27-37. No abstract available.

PMID:
2461590
[PubMed - indexed for MEDLINE]
12.

Defibrotide affects the anticoagulant and lipase-releasing activities of heparin.

Porta R, Pescador R, Mantovani M, Prino G.

Haemostasis. 1990;20(6):347-56.

PMID:
2099323
[PubMed - indexed for MEDLINE]
13.

The anti-ischemic drugs defibrotide and oligotide analogously inhibit leukocyte-endothelial cell adhesion in vitro.

Pellegatta F, Ferrero E, Marni A, Chierchia S, Forti D, Ferrero ME.

Transpl Int. 1996;9 Suppl 1:S420-4.

PMID:
8959877
[PubMed - indexed for MEDLINE]
14.

Effects of defibrotide on fibrinolytic activity in diabetic patients with stable angina pectoris.

Davì G, Catalano I, Belvedere M, Amato S, Mogavero A, Giammarresi C, Alaimo P, Notarbartolo A.

Thromb Res. 1992 Jan 15;65(2):211-20.

PMID:
1579896
[PubMed - indexed for MEDLINE]
15.

Increased plasma t-PA activity and urinary PGE2 after repeated oral administration of defibrotide to the rat and the mouse.

Nunziata A, Mariani MF, Cascone M, Calvani AB, Pescador R.

Thromb Res. 1991 Oct 15;64(2):279-84. No abstract available.

PMID:
1811346
[PubMed - indexed for MEDLINE]
16.

Subcellular localization of radioactively labelled defibrotide in cultured endothelial cells.

Bilsel S, Erşahin C, Taga Y, Emerk K.

Thromb Res. 1992 May 15;66(4):385-90.

PMID:
1412204
[PubMed - indexed for MEDLINE]
17.

Effects of defibrotide on aorta and brain malondialdehyde and antioxidants in cholesterol-induced atherosclerotic rabbits.

Aydemir EO, Duman C, Celik HA, Turgan N, Uysal A, Mutaf I, Habif S, Ozmen D, Nişli N, Bayindir O.

Int J Clin Lab Res. 2000;30(2):101-7.

PMID:
11043504
[PubMed - indexed for MEDLINE]
18.

A novel insight into the mechanism of the antithrombotic action of defibrotide.

Tettamanti R, Bianchi G, Vitte PA, Kato G, Porta R, Thiemermann C, Pescador R, Mantovani M.

Life Sci. 1992;51(19):1545-55.

PMID:
1331634
[PubMed - indexed for MEDLINE]
19.

Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.

Booyse FM, Lin PH, Traylor M, Bruce R.

J Biol Chem. 1988 Oct 15;263(29):15139-45.

PMID:
3170576
[PubMed - indexed for MEDLINE]
Free Article
20.

New in vivo model to assess venous endothelial cell functions. Effect of defibrotide.

Di Perri T, Laghi Pasini F, Frigerio C, Capecchi PL, Messa GL, Franchi M, Landini F, Burresi A, Ghezzi A, Ceccatelli L, et al.

Eur J Clin Pharmacol. 1989;37(4):351-7.

PMID:
2557218
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk